tradingkey.logo
tradingkey.logo
Search

Sagimet Biosciences Inc

SGMT
Add to Watchlist
7.010USD
0.0000.00%
Close 07-23 16:00ETQuotes delayed by 15 min
228.42MMarket Cap
LossP/E TTM

SGMT Financials

See Sagimet Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Sagimet Biosciences Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.33/-0.37
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.58
-8.56%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q1
Financial Indicators
EPS
42.06%-0.33
41.36%-0.29
12.58%-0.40
-26.82%-0.32
-147.31%-0.56
-44.31%-0.50
-30.25%-0.45
16.87%-0.25
25.32%-0.23
---0.35
---0.35
---0.31
---0.31
----
----
----
----
----
Revenue
----
----
----
----
----
--0.00
-100.00%0.00
----
----
--0.00
--2.00M
----
----
----
----
----
----
----
Net Profit
41.41%-10.65M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-98.76%-16.20M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
---8.15M
---6.35M
4.46%-6.79M
24.59%-6.59M
----
---7.10M
-57.44%-8.73M
----
---5.55M
Net Margin
----
----
----
----
----
----
----
----
----
----
---317.65%
----
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
--100.00%
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.02%
--0.02%
----
----
----
----
----
Revenue
----
----
----
----
----
--0.00
-100.00%0.00
----
----
--0.00
--2.00M
----
----
----
----
----
----
----
Operating profit
41.04%-11.71M
40.84%-10.77M
15.19%-14.33M
-12.62%-11.93M
-126.56%-19.86M
-92.21%-18.20M
-126.81%-16.90M
-50.05%-10.59M
-29.61%-8.77M
---9.47M
---7.45M
2.50%-7.06M
22.62%-6.76M
----
---7.24M
-82.03%-8.74M
----
---4.80M
Net Profit
41.41%-10.65M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-98.76%-16.20M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
---8.15M
---6.35M
4.46%-6.79M
24.59%-6.59M
----
---7.10M
-57.44%-8.73M
----
---5.55M
Current assets
-26.26%107.72M
-23.81%116.40M
-23.99%119.48M
-23.72%127.20M
-24.90%146.07M
58.08%152.77M
52.88%157.19M
680.89%166.75M
619.06%194.49M
--96.65M
--102.82M
--21.35M
--27.05M
----
----
----
--58.66M
--77.01M
Total current liabilities
-26.23%5.30M
14.53%5.10M
123.51%9.15M
26.52%7.25M
59.20%7.18M
-21.22%4.45M
-18.95%4.09M
8.34%5.73M
-14.70%4.51M
--5.65M
--5.05M
--5.29M
--5.29M
----
----
----
--2.44M
--3.13M
Total assets
-26.28%107.75M
-27.32%116.48M
-26.53%128.40M
-27.31%137.41M
-24.86%146.17M
65.70%160.26M
69.81%174.78M
779.24%189.02M
613.79%194.53M
--96.72M
--102.92M
--21.50M
--27.25M
----
----
----
--59.03M
--77.20M
Total liabilities
-26.23%5.30M
14.53%5.10M
123.51%9.15M
26.52%7.25M
59.20%7.18M
-21.22%4.45M
-18.94%4.09M
8.24%5.73M
-15.42%4.51M
--5.65M
--5.05M
--5.29M
--5.33M
----
----
----
--2.67M
--3.16M
Total equity
-26.28%102.46M
-28.51%111.38M
-30.13%119.25M
-28.99%130.16M
-26.85%138.99M
71.09%155.81M
74.38%170.68M
1031.01%183.29M
766.83%190.02M
--91.06M
--97.88M
--16.21M
--21.92M
----
----
----
--56.36M
--74.04M
Net operating income
40.76%-8.61M
-7.34%-11.83M
47.98%-10.18M
-61.54%-9.10M
-134.15%-14.54M
-55.64%-11.02M
-404.49%-19.57M
1.50%-5.63M
12.37%-6.21M
---7.08M
---3.88M
6.81%-5.72M
-51.85%-7.08M
----
---6.14M
-79.56%-4.67M
----
---2.60M
Net investment
199.33%10.22M
45.77%14.36M
-87.98%75.00K
82.32%-13.29M
13.77%3.41M
150.20%9.85M
--624.00K
-687.16%-75.16M
-84.54%3.00M
---19.62M
--0.00
130.88%12.80M
--19.40M
----
---41.45M
--0.00
----
----
Net financing
----
--0.00
--274.00K
103.70%1.00K
-100.00%0.00
--0.00
-100.00%0.00
97.03%-27.00K
77192.65%104.85M
--0.00
--87.21M
-2933.33%-910.00K
-1233.33%-136.00K
----
---30.00K
--12.00K
----
--0.00

FAQs

What are the current assets of Sagimet Biosciences Inc?

According to Sagimet Biosciences Inc's FY2025 earnings report, its current assets were 116.40M, with a year-on-year change of -23.81.

What are the total assets of Sagimet Biosciences Inc?

According to Sagimet Biosciences Inc's FY2025 earnings report, its total assets of Sagimet Biosciences Inc were 116.48M, with a year-on-year change of -27.32.

What are the total liabilities of Sagimet Biosciences Inc?

According to Sagimet Biosciences Inc's FY2025 earnings report, its total liabilities of Sagimet Biosciences Inc were 5.10M, with a year-on-year change of 14.53.

What is the total equity of Sagimet Biosciences Inc?

According to Sagimet Biosciences Inc's FY2025 earnings report, its total equity of Sagimet Biosciences Inc was 111.38M, with a year-on-year change of -28.51.

What is the net operating income of Sagimet Biosciences Inc?

According to Sagimet Biosciences Inc's FY2025 earnings report, its net operating income of Sagimet Biosciences Inc was -56.89M, with a year-on-year change of -4.47.

What is the net investment of Sagimet Biosciences Inc?

According to Sagimet Biosciences Inc's FY2025 earnings report, its net investment of Sagimet Biosciences Inc was 4.56M, with a year-on-year change of 107.39.

What is the net financing of Sagimet Biosciences Inc?

According to Sagimet Biosciences Inc's FY2025 earnings report, its net financing of Sagimet Biosciences Inc was 275.00K, with a year-on-year change of -99.74.

What is the Earnings Per Share (EPS) of Sagimet Biosciences Inc?

According to Sagimet Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.58, with a year-on-year change of -8.56.

What is the net income of Sagimet Biosciences Inc?

According to Sagimet Biosciences Inc's FY2025 earnings report, its net income was -51.04M, with a year-on-year change of -12.01.

What is the Return on Equity (ROE) of Sagimet Biosciences Inc?

According to Sagimet Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -38.20, with a year-on-year change of -3.49.

What is the Return on Assets (ROA) of Sagimet Biosciences Inc?

According to Sagimet Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -36.89, with a year-on-year change of -4.01.

What is the operating profit of Sagimet Biosciences Inc?

According to Sagimet Biosciences Inc's FY2025 earnings report, its operating profit was -56.89M, with a year-on-year change of -4.47.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.